The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 15, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 6
- −1 vs. Q1 2024
- Portfolio value
- $71.3M
- −$89.3M (−55.6%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $29.1M | 40.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,540,777 | $25.0M | 35.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 810,088 | $8.87M | 12.4% | +193,548+31.4% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $8.18M | 11.5% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 17,169 | $58.7K | 0.1% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 46 | $1.78K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2024 (1)
Positions held at the end of Q1 2024 that are gone from this filing.